Metaproterenol Sulfate

   
Google
 
Web NewDrugInformation.com

Metaproterenol Sulfate


Drug - Metaproterenol Sulfate
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; INHALATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Metaproterenol Sulfate
Multiple ingredients are in alphabetical order.

Strength - 0.6%
The potency of the active ingredient(s), Metaproterenol Sulfate. May repeat for multiple part products.

Applicant - NEPHRON
The firm name holding legal responsibility for Metaproterenol Sulfate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 071726
The FDA assigned number to Metaproterenol Sulfate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Metaproterenol Sulfate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AN
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 14, 1988
The date Metaproterenol Sulfate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Metaproterenol Sulfate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Metaproterenol Sulfate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Nephron Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Metaproterenol Sulfate.

Metaproterenol Sulfate